Search Result "11q23 abnormalities"
The Prognosis and Treatment of Adult Acute Leukemia with 11q23/MLL According to the Fusion Partner
Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 3 Year: 2009 Page: 227-231
Author(s): Hayato Tamai, Hiroki Yamaguchi, Koiti Inokuchi, Kazuo Dan
Cytogenetic and Molecular Abnormalities in Myelodysplastic Syndrome
Journal: Current Molecular Medicine
Volume: 11 Issue: 8 Year: 2011 Page: 678-685
Author(s): H. Nagoshi, S. Horiike, J. Kuroda, M. Taniwaki
Recurrence in Bladder Cancer: A Molecular Dead End?
Journal: Current Genomics
Volume: 4 Issue: 5 Year: 2003 Page: 417-434
Author(s): John M. S. Bartlett, Joanne Edwards, Ken M. Grigor
MicroRNAs in Leukemias: Emerging Diagnostic Tools and Therapeutic Targets
Journal: Current Drug Targets
Volume: 11 Issue: 7 Year: 2010 Page: 801-811
Author(s): Yousaf A. Mian, Nancy J. Zeleznik-Le
Use of Single Nucleotide Polymorphism Array Technology to Improve the Identification of Chromosomal Lesions in Leukemia
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 7 Year: 2013 Page: 791-810
Author(s): Ilaria Iacobucci, Annalisa Lonetti, Cristina Papayannidis, Giovanni Martinelli
Single Autosomal Trisomy in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Journal: Current Genomics
Volume: 1 Issue: 2 Year: 2000 Page: 153-173
Author(s): S. K. Ma, T. S.K. Wan
Targeting Epigenetics through Histone Deacetylase Inhibitors in Acute Lymphoblastic Leukemia
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 7 Year: 2011 Page: 882-893
Author(s): A. Mummery, A. Narendran, K.-Y. Lee
MicroRNA Involvement in the Pathogenesis of Neuroblastoma: Potential for MicroRNA Mediated Therapeutics
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 4 Year: 2009 Page: 456-462
Author(s): R. L. Stallings
Chromosomal Translocations in Hematologic Malignancies
Journal: Current Genomics
Volume: 3 Issue: 4 Year: 2002 Page: 313-334
Author(s): Claudio G. Brunstein, Scott J. Dylla, Catherine M. Verfaillie
Epigenetic and Genetics Factors
Ebook: Molecular Targets and Cancer Therapeutics (Part 1)
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815080384123010011